S 974
115th Congress
Senate
Health
Civil actions and liability
Drug safety, medical device, and laboratory regulation
Licensing and registrations
Prescription drugs
Product development and innovation
CREATES Act of 2018
Introduced: April 27, 2017
See on congress.gov
Everywhere this bill has been
5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 21, 2018
Placed on Senate Legislative Calendar under General Orders. Calendar No. 482.
Jun 21, 2018
Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.
Jun 14, 2018
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
Apr 27, 2017
Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S2619)
Apr 27, 2017
Introduced in Senate
Plain-English summary
Creating and Restoring Equal Access To Equivalent Samples Act of 2017 or the CREATES Act of 2017
This bill permits the developer of a drug or biological product to bring a civil action against the license holder of an approved drug or biological product if the holder has declined to make available sufficient quantities of the approved drug or product for the developer's testing.
What's happening now
Placed on Senate Legislative Calendar under General Orders. Calendar No. 482.
Committees of jurisdiction
1